Table 1 Response categorization on CE-CT and 2-[18F]FDG-PET/CT for the first follow-up scan in 87 patients.

From: 2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

Response category

2-[18F]FDG-PET/CT

N (%)

CE-CT

N (%)

Total

87 (100)

87 (100)

Responders

 C(M)R

8 (9.2)

66 (75.9)

2 (2.3)

25 (28.7)

 P(M)R

58 (66.7)

23 (26.4)

Non-responders

 S(M)D

13 (14.9)

21 (24.1)

59 (67.8)

62 (71.3)

 P(M)D

8 (9.2)

3 (3.5)

  1. C(M)R complete (metabolic) response, P(M)R partial (metabolic) response, S(M)D stable (metabolic) disease, P(M)D progressive (metabolic) disease.
Back to article page